{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T22:03:41Z","timestamp":1772229821901,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T00:00:00Z","timestamp":1518998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008156","name":"Carolinas HealthCare Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008156","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Carolinas Medical Center"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.omtn.2018.02.004","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T12:47:18Z","timestamp":1519217238000},"page":"192-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Saponins as Natural Adjuvant for Antisense Morpholino Oligonucleotides Delivery In\u00a0Vitro and in mdx Mice"],"prefix":"10.1016","volume":"11","author":[{"given":"Mingxing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sapana N.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peijuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qilong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2018.02.004_bib1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2018.02.004_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2018.02.004_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbadis.2006.06.009","article-title":"Current treatment of adult Duchenne muscular dystrophy","volume":"1772","author":"Wagner","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtn.2018.02.004_bib4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2018.02.004_bib5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy","volume":"351","author":"Long","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omtn.2018.02.004_bib6","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1021\/bc070060v","article-title":"Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate","volume":"18","author":"Amantana","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omtn.2018.02.004_bib7","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1011367","article-title":"Systemic administration of PRO051 in Duchenne\u2019s muscular dystrophy","volume":"364","author":"Goemans","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2018.02.004_bib8","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1474-4422(09)70211-X","article-title":"Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study","volume":"8","author":"Kinali","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtn.2018.02.004_bib9","first-page":"498","article-title":"The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion","volume":"45","author":"Koenig","year":"1989","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2018.02.004_bib10","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nm897","article-title":"Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse","volume":"9","author":"Lu","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2018.02.004_bib11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1073\/pnas.0406700102","article-title":"Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles","volume":"102","author":"Lu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2018.02.004_bib12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of Duchenne muscular dystrophy","volume":"74","author":"Mendell","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2018.02.004_bib13","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1056\/NEJMoa073108","article-title":"Local dystrophin restoration with antisense oligonucleotide PRO051","volume":"357","author":"van Deutekom","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2018.02.004_bib14","doi-asserted-by":"crossref","first-page":"14814","DOI":"10.1073\/pnas.0805676105","article-title":"Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer","volume":"105","author":"Wu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2018.02.004_bib15","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/mt.2009.38","article-title":"Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice","volume":"17","author":"Wu","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.02.004_bib16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/gt.2009.120","article-title":"Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino","volume":"17","author":"Wu","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2018.02.004_bib17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ajpath.2012.04.006","article-title":"Long-term rescue of dystrophin expression and improvement in muscle pathology and function in dystrophic mdx mice by peptide-conjugated morpholino","volume":"181","author":"Wu","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtn.2018.02.004_bib18","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1093\/hmg\/ddn293","article-title":"Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function","volume":"17","author":"Yin","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2018.02.004_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addr.2015.03.008","article-title":"Antisense oligonucleotides in therapy for neurodegenerative disorders","volume":"87","author":"Evers","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2018.02.004_bib20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2018.02.004_bib21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/mt.2010.261","article-title":"Chronic systemic therapy with low-dose morpholino oligomers ameliorates the pathology and normalizes locomotor behavior in mdx mice","volume":"19","author":"Malerba","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.02.004_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/oli.1.1997.7.187","article-title":"Morpholino antisense oligomers: design, preparation, and properties","volume":"7","author":"Summerton","year":"1997","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/j.omtn.2018.02.004_bib23","first-page":"1","article-title":"New antisense strategies: chemical synthesis of RNA oligomers","volume":"Volume 249","author":"Yano","year":"2011"},{"key":"10.1016\/j.omtn.2018.02.004_bib24","doi-asserted-by":"crossref","first-page":"164ra160","DOI":"10.1126\/scitranslmed.3005054","article-title":"Dantrolene enhances antisense-mediated exon skipping in human and mouse models of Duchenne muscular dystrophy","volume":"4","author":"Kendall","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2018.02.004_bib25","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1038\/mtna.2016.46","article-title":"Fructose promotes uptake and activity of oligonucleotides with different chemistries in a context-dependent manner in mdx mice","volume":"5","author":"Cao","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2018.02.004_bib26","doi-asserted-by":"crossref","first-page":"10981","DOI":"10.1038\/ncomms10981","article-title":"Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice","volume":"7","author":"Han","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2018.02.004_bib27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/mt.2012.236","article-title":"Polyethylenimine-modified pluronics (PCMs) improve morpholino oligomer delivery in cell culture and dystrophic mdx mice","volume":"21","author":"Wang","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.02.004_bib28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1089\/hum.2013.156","article-title":"Evaluation of Tris[2-(acryloyloxy)ethyl]isocyanurate cross-linked polyethylenimine as antisense morpholino oligomer delivery vehicle in cell culture and dystrophic mdx mice","volume":"25","author":"Wang","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2018.02.004_bib29","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1039\/C5TB00139K","article-title":"Tween 85 grafted PEIs enhanced delivery of antisense 2\u2032-O-methyl phosphorothioate oligonucleotides in\u00a0vitro and in dystrophic mdx mice","volume":"3","author":"Wang","year":"2015","journal-title":"J.\u00a0Mater. Chem. B"},{"key":"10.1016\/j.omtn.2018.02.004_bib30","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.2147\/IJN.S89910","article-title":"Cationic polyelectrolyte-mediated delivery of antisense morpholino oligonucleotides for exon-skipping in\u00a0vitro and in mdx mice","volume":"10","author":"Wang","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.omtn.2018.02.004_bib31","series-title":"Saponins in Food, Feedstuffs and Medicinal Plants","first-page":"233","article-title":"Glycoside based adjuvants","author":"Ferreira","year":"2000"},{"key":"10.1016\/j.omtn.2018.02.004_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1631\/jzus.2007.B0153","article-title":"Adjuvant effects of saponins on animal immune responses","volume":"8","author":"Rajput","year":"2007","journal-title":"J.\u00a0Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.omtn.2018.02.004_bib33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/ijms17030325","article-title":"Adjuvant effect of Quillaja saponaria saponin (QSS) on protective efficacy and IgM generation in turbot (Scophthalmus maximus) upon immersion vaccination","volume":"17","author":"Wang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2018.02.004_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2005.03.032","article-title":"The use of digitonin-permeabilized mammalian cells for measuring enzyme activities in the course of studies on lipid metabolism","volume":"347","author":"Geelen","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.omtn.2018.02.004_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0143-4160(85)90032-6","article-title":"Intracellular levels and distribution of Ca2+ in digitonin-permeabilized cells","volume":"6","author":"Fiskum","year":"1985","journal-title":"Cell Calcium"},{"key":"10.1016\/j.omtn.2018.02.004_bib36","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B","article-title":"The long term efficacy of glycyrrhizin in chronic hepatitis C patients","volume":"79","author":"Arase","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.omtn.2018.02.004_bib37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2036.1998.00309.x","article-title":"Review article: glycyrrhizin as a potential treatment for chronic hepatitis C","volume":"12","author":"van Rossum","year":"1998","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.omtn.2018.02.004_bib38","doi-asserted-by":"crossref","first-page":"9534","DOI":"10.1021\/jf402654e","article-title":"Anticarcinogenic, cardioprotective, and other health benefits of tomato compounds lycopene, \u03b1-tomatine, and tomatidine in pure form and in fresh and processed tomatoes","volume":"61","author":"Friedman","year":"2013","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.omtn.2018.02.004_bib39","doi-asserted-by":"crossref","first-page":"14913","DOI":"10.1074\/jbc.M114.556241","article-title":"Systems-based discovery of tomatidine as a natural small molecule inhibitor of skeletal muscle atrophy","volume":"289","author":"Dyle","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2018.02.004_bib40","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/mt.2009.320","article-title":"Guanine analogues enhance antisense oligonucleotide-induced exon skipping in dystrophin gene in\u00a0vitro and in\u00a0vivo","volume":"18","author":"Hu","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.02.004_bib41","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1093\/nar\/29.19.3965","article-title":"Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs","volume":"29","author":"Sazani","year":"2001","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253118300180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253118300180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:12:34Z","timestamp":1772226754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253118300180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":41,"alternative-id":["S2162253118300180"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2018.02.004","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Saponins as Natural Adjuvant for Antisense Morpholino Oligonucleotides Delivery In\u00a0Vitro and in mdx Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2018.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s).","name":"copyright","label":"Copyright"}]}}